Previously, flavonoids have been reported to inactivate frequently deregulated pathways, such as Akt and NF-κB, in pancreatic cancer, contributing to cell growth, metastasis and chemo resistance. The gene discussed is AKT1; the disease is pancreatic neoplasm.